Exclusive: Lonza in talks to buy Capsugel for more than $5 billion - sources

(Reuters) - Swiss pharmaceutical manufacturer Lonza Group AG is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people familiar with the matter.

Exclusive: Lonza in talks to buy Capsugel for more than $5 billion - sources
Read More


Bagikan Berita Ini